Ajanta Pharma Ltd Competitors & Peer Comparison
Pharmaceuticals · Indian listed companies
Compare Ajanta Pharma Ltd with 125 companies shown from the same industry classification, including Glaxosmithkline Pharmaceuticals Ltd, J B Chemicals & Pharmaceuticals Ltd, Ipca Laboratories Ltd. These are industry peers; their products, customers and business models may differ.
Selected-company price and ratio data: . Peer reporting dates can differ. Stored figures, not live quotes.
Compare valuation, size and returns
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Ajanta Pharma Ltd | 42,592 Cr. | 3,410 | 3,797/2,380 | 37.5 | 362 | 0.94 % | 34.5 % | 27.1 % | 2.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 43,030 Cr. | 2,540 | 3,121/2,088 | 40.9 | 134 | 2.24 % | 61.4 % | 45.6 % | 10.0 |
| J B Chemicals & Pharmaceuticals Ltd | 38,677 Cr. | 2,409 | 2,526/1,642 | 53.8 | 259 | 0.91 % | 25.4 % | 18.9 % | 1.00 |
| Ipca Laboratories Ltd | 48,830 Cr. | 1,915 | 2,039/1,252 | 35.6 | 318 | 0.31 % | 17.0 % | 15.7 % | 1.00 |
| Gland Pharma Ltd | 50,674 Cr. | 3,062 | 3,171/1,574 | 35.9 | 656 | 0.65 % | 17.4 % | 12.8 % | 1.00 |
| Wockhardt Ltd | 32,416 Cr. | 1,996 | 2,422/1,087 | 81.3 | 304 | 0.00 % | 7.55 % | 6.11 % | 5.00 |
| Abbott India Ltd | 55,143 Cr. | 26,000 | 30,655/25,135 | 34.2 | 2,247 | 2.02 % | 44.8 % | 34.4 % | 10.0 |
| Biocon Ltd | 57,105 Cr. | 349 | 447/338 | 78.5 | 210 | 0.14 % | 3.61 % | 1.40 % | 5.00 |
| Neuland Laboratories Ltd | 26,802 Cr. | 20,890 | 24,235/11,500 | 53.8 | 1,461 | 0.16 % | 26.5 % | 21.2 % | 10.0 |
| Acutaas Chemicals Ltd | 25,039 Cr. | 3,057 | 3,740/1,380 | 64.8 | 202 | 0.08 % | 31.6 % | 24.0 % | 5.00 |
| Glenmark Life Sciences Ltd | 62,243 Cr. | 2,210 | 2,538/1,793 | 20.0 | 372 | 0.23 % | 39.8 % | 23.6 % | 1.00 |
| Granules India Ltd | 22,234 Cr. | 815 | 924/520 | 34.2 | 205 | 0.21 % | 15.5 % | 13.8 % | 1.00 |
| Alkem Laboratories Ltd | 63,221 Cr. | 5,279 | 5,934/5,051 | 27.8 | 1,156 | 1.00 % | 21.2 % | 18.9 % | 2.00 |
| Glenmark Pharmaceuticals Ltd | 64,200 Cr. | 2,293 | 2,538/1,793 | 20.6 | 372 | 0.22 % | 39.8 % | 23.6 % | 1.00 |
| Shilpa Medicare Ltd | 19,964 Cr. | 1,022 | 1,096/260 | 70.2 | 132 | 0.06 % | 10.9 % | 8.99 % | 1.00 |
| Caplin Point Laboratories Ltd | 18,691 Cr. | 2,461 | 2,991/1,500 | 28.1 | 443 | 0.33 % | 24.2 % | 20.9 % | 2.00 |
| Pfizer Ltd | 17,424 Cr. | 3,808 | 5,578/3,731 | 22.7 | 919 | 1.97 % | 24.1 % | 18.0 % | 10.0 |
| Cohance Lifesciences Ltd | 16,867 Cr. | 441 | 918/267 | 157 | 102 | 0.00 % | 5.81 % | 4.89 % | 1.00 |
| ERIS Lifesciences Ltd | 16,326 Cr. | 1,171 | 1,740/1,141 | 24.9 | 282 | 0.62 % | 14.1 % | 18.7 % | 1.00 |
| Alembic Pharmaceuticals Ltd | 15,746 Cr. | 801 | 998/635 | 21.1 | 289 | 1.50 % | 12.6 % | 13.4 % | 2.00 |
| Natco Pharma Ltd | 15,474 Cr. | 789 | 1,217/786 | 13.5 | 470 | 0.63 % | 17.4 % | 17.1 % | 2.00 |
| Jubilant Pharmova Ltd | 14,844 Cr. | 932 | 1,185/784 | 38.2 | 445 | 0.54 % | 8.99 % | 6.53 % | 1.00 |
| Astrazeneca Pharma India Ltd | 14,632 Cr. | 5,837 | 9,850/5,640 | 84.3 | 349 | 0.62 % | 29.3 % | 23.3 % | 2.00 |
| Marksans Pharma Ltd | 14,003 Cr. | 309 | 351/155 | 27.1 | 66.7 | 0.29 % | 18.8 % | 15.2 % | 1.00 |
| Concord Biotech Ltd | 13,948 Cr. | 1,331 | 1,627/987 | 49.0 | 193 | 0.57 % | 17.4 % | 12.6 % | 1.00 |
| Blue Jet Healthcare Ltd | 9,824 Cr. | 519 | 693/325 | 41.8 | 78.4 | 0.23 % | 26.1 % | 19.4 % | 2.00 |
| Sequent Scientific Ltd | 8,768 Cr. | 201 | 260/111 | 203 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Procter & Gamble Health Ltd | 8,638 Cr. | 5,205 | 6,975/4,700 | 25.9 | 316 | 2.98 % | 83.9 % | 61.9 % | 10.0 |
| Suven Life Sciences Ltd | 7,998 Cr. | 283 | 403/124 | 22.4 | 0.00 % | 79.5 % | 81.5 % | 1.00 | |
| Aarti Pharmalabs Ltd | 7,755 Cr. | 856 | 1,002/584 | 36.0 | 234 | 0.41 % | 10.7 % | 8.59 % | 5.00 |
| Entero Healthcare Solutions Ltd | 7,349 Cr. | 1,689 | 1,920/944 | 57.0 | 388 | 0.00 % | 10.5 % | 6.94 % | 10.0 |
| Morepen Laboratories Ltd | 7,096 Cr. | 130 | 151/33.0 | 60.4 | 22.8 | 0.15 % | 8.05 % | 5.33 % | 2.00 |
| Bliss GVS Pharma Ltd | 6,937 Cr. | 656 | 745/118 | 50.4 | 113 | 0.23 % | 16.9 % | 11.8 % | 1.00 |
| Sanofi India Ltd | 6,779 Cr. | 2,945 | 4,898/2,914 | 19.8 | 359 | 2.55 % | 57.5 % | 43.0 % | 10.0 |
| IOL Chemicals & Pharmaceuticals Ltd | 5,900 Cr. | 201 | 224/67.1 | 33.4 | 61.3 | 0.50 % | 11.3 % | 8.42 % | 2.00 |
| Orchid Pharma Ltd | 5,891 Cr. | 984 | 1,144/471 | 326 | 300 | 0.00 % | 1.86 % | 1.49 % | 10.0 |
| FDC Ltd | 5,370 Cr. | 330 | 474/313 | 17.4 | 153 | 1.51 % | 15.4 % | 11.2 % | 1.00 |
| Gujarat Themis Biosyn Ltd | 4,812 Cr. | 370 | 479/225 | 98.9 | 26.4 | 0.18 % | 18.1 % | 17.4 % | 1.00 |
| Zota Health Care Ltd | 4,586 Cr. | 1,324 | 1,740/1,022 | 200 | 0.08 % | 8.47 % | 15.0 % | 10.0 | |
| RPG Life Sciences Ltd | 4,502 Cr. | 2,719 | 3,130/1,731 | 38.6 | 366 | 0.88 % | 25.7 % | 19.3 % | 8.00 |
| SMS Pharmaceuticals Ltd | 4,163 Cr. | 445 | 494/269 | 46.0 | 85.9 | 0.09 % | 12.9 % | 11.9 % | 1.00 |
| Gufic BioSciences Ltd | 4,080 Cr. | 406 | 468/268 | 55.5 | 66.2 | 0.02 % | 12.2 % | 9.98 % | 1.00 |
| Aarti Drugs Limited | 3,763 Cr. | 413 | 534/319 | 21.8 | 154 | 0.48 % | 11.7 % | 12.7 % | 10.0 |
| Unichem Laboratories Ltd | 3,752 Cr. | 531 | 687/278 | 30.7 | 386 | 0.00 % | 4.13 % | 3.17 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 3,702 Cr. | 3,564 | 3,949/829 | 45.3 | 321 | 0.00 % | 23.9 % | 22.5 % | 10.0 |
| Ind-Swift Laboratories Ltd | 3,132 Cr. | 361 | 425/87.0 | 48.1 | 159 | 0.00 % | 4.86 % | 4.02 % | 10.0 |
| Solara Active Pharma Sciences Ltd | 3,126 Cr. | 644 | 774/422 | 732 | 346 | 0.00 % | 4.86 % | 0.13 % | 10.0 |
| Advanced Enzyme Technologies Ltd | 2,990 Cr. | 267 | 420/252 | 19.0 | 146 | 2.00 % | 14.0 % | 10.2 % | 2.00 |
| Hikal Ltd | 2,640 Cr. | 214 | 261/146 | 62.3 | 97.2 | 0.28 % | 3.50 % | 2.21 % | 2.00 |
| Fredun Pharmaceuticals Ltd | 2,529 Cr. | 1,532 | 1,666/454 | 56.9 | 170 | 0.02 % | 21.5 % | 15.8 % | 10.0 |
| Dishman Carbogen Amcis Ltd | 2,345 Cr. | 150 | 306/128 | 129 | 426 | 0.00 % | 3.14 % | 1.58 % | 2.00 |
| Syncom Formulations (India) Ltd | 2,187 Cr. | 23.3 | 27.5/10.2 | 25.8 | 4.39 | 0.43 % | 24.8 % | 17.6 % | 1.00 |
| Beta Drugs Ltd | 2,162 Cr. | 1,950 | 2,808/990 | 47.4 | 241 | 0.00 % | 19.2 % | 18.8 % | 10.0 |
| Venus Remedies Ltd | 2,159 Cr. | 1,610 | 2,044/432 | 18.6 | 497 | 0.62 % | 20.7 % | 15.6 % | 10.0 |
| Indoco Remedies Ltd | 2,129 Cr. | 231 | 317/162 | 102 | 0.09 % | 0.96 % | 9.36 % | 2.00 | |
| Panacea Biotec Ltd | 2,119 Cr. | 345 | 648/292 | 136 | 0.00 % | 2.43 % | 2.42 % | 1.00 | |
| Hester Biosciences Ltd | 1,765 Cr. | 2,059 | 2,684/1,239 | 33.2 | 423 | 0.53 % | 15.2 % | 15.9 % | 10.0 |
| Fermenta Biotech Ltd | 1,587 Cr. | 540 | 583/249 | 29.0 | 138 | 0.69 % | 20.6 % | 16.4 % | 5.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,495 Cr. | 226 | 265/155 | 31.8 | 41.2 | 1.77 % | 22.7 % | 17.3 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,468 Cr. | 509 | 760/476 | 23.6 | 128 | 0.96 % | 24.8 % | 18.4 % | 1.00 |
| TTK Healthcare Ltd | 1,434 Cr. | 1,017 | 1,250/735 | 18.7 | 789 | 0.98 % | 8.04 % | 6.30 % | 10.0 |
| Kopran Ltd | 1,215 Cr. | 251 | 296/107 | 48.6 | 110 | 1.19 % | 6.65 % | 4.91 % | 10.0 |
| Lincoln Pharmaceuticals Ltd | 1,121 Cr. | 558 | 770/440 | 11.6 | 378 | 0.32 % | 16.3 % | 12.3 % | 10.0 |
| Themis Medicare Ltd | 995 Cr. | 109 | 141/65.0 | 43.3 | 0.46 % | 2.74 % | 0.41 % | 1.00 | |
| Bafna Pharmaceuticals Ltd | 973 Cr. | 418 | 425/94.8 | 125 | 40.6 | 0.00 % | 11.9 % | 12.3 % | 10.0 |
| Kilitch Drugs (India) Ltd | 847 Cr. | 242 | 268/117 | 28.2 | 80.0 | 0.00 % | 13.4 % | 10.6 % | 10.0 |
| Anuh Pharma Ltd | 820 Cr. | 81.6 | 99.5/66.7 | 18.6 | 35.1 | 1.83 % | 14.9 % | 10.7 % | 5.00 |
| Wanbury Ltd | 687 Cr. | 196 | 360/162 | 16.0 | 18.1 | 0.00 % | 36.6 % | 76.5 % | 10.0 |
| Albert David Ltd | 448 Cr. | 792 | 932/580 | 19.9 | 686 | 0.63 % | 0.82 % | 0.44 % | 10.0 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Aarey Drugs & Pharmaceuticals Ltd | 337 Cr. | 104 | 110/50.3 | 80.8 | 53.0 | 0.00 % | 5.58 % | 2.75 % | 10.0 |
| BDH Industries Ltd | 274 Cr. | 475 | 610/340 | 23.4 | 134 | 1.05 % | 20.5 % | 14.8 % | 10.0 |
| Lyka Labs Ltd | 263 Cr. | 72.6 | 105/44.1 | 25.9 | 0.00 % | 5.98 % | 10.2 % | 10.0 | |
| Everest Organics Ltd | 241 Cr. | 242 | 536/197 | 45.9 | 77.7 | 0.00 % | 12.0 % | 7.63 % | 10.0 |
| Gennex Laboratories Ltd | 237 Cr. | 9.77 | 17.2/7.05 | 12.6 | 9.16 | 0.00 % | 11.8 % | 10.5 % | 1.00 |
| Brooks Laboratories Ltd | 204 Cr. | 70.1 | 132/36.3 | 15.4 | 41.6 | 0.00 % | 21.2 % | 22.0 % | 10.0 |
| Ambalal Sarabhai Enterprises Ltd | 203 Cr. | 26.5 | 42.0/23.1 | 11.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Nectar Lifescience Ltd | 198 Cr. | 10.1 | 22.5/9.20 | 30.0 | 0.00 % | 0.05 % | 31.3 % | 1.00 | |
| Coral Laboratories Ltd | 193 Cr. | 540 | 679/360 | 10.2 | 585 | 0.37 % | 11.0 % | 7.79 % | 10.0 |
| Bal Pharma Ltd | 149 Cr. | 93.1 | 125/59.7 | 20.6 | 51.6 | 1.29 % | 9.75 % | 7.79 % | 10.0 |
| Auro Laboratories Ltd | 147 Cr. | 236 | 317/159 | 30.8 | 74.4 | 0.00 % | 9.52 % | 8.49 % | 10.0 |
| Par Drugs & Chemicals Ltd | 144 Cr. | 117 | 180/78.0 | 9.94 | 91.0 | 0.00 % | 14.6 % | 9.95 % | 10.0 |
| Godavari Drugs Ltd | 141 Cr. | 129 | 135/69.7 | 36.2 | 74.8 | 0.00 % | 6.55 % | 6.14 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 139 Cr. | 9.49 | 14.3/1.96 | 46.3 | 0.81 | 0.00 % | 22.9 % | 16.6 % | 1.00 |
| Lactose (India) Ltd | 135 Cr. | 107 | 136/76.0 | 19.4 | 51.5 | 0.00 % | 11.3 % | 9.81 % | 10.0 |
| Achyut Healthcare Ltd | 132 Cr. | 5.47 | 10.0/4.70 | 413 | 1.45 | 0.00 % | 1.18 % | 0.96 % | 1.00 |
| Krebs Biochemicals & Industries Ltd | 121 Cr. | 56.0 | 76.8/38.3 | 75.5 | 0.00 % | 15.4 % | % | 10.0 | |
| Alpa Laboratories Ltd | 120 Cr. | 57.0 | 99.8/46.0 | 27.5 | 93.4 | 0.00 % | 8.91 % | 7.90 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 109 Cr. | 30.8 | 53.9/25.6 | 13.5 | 0.00 % | 18.5 % | 26.5 % | 10.0 | |
| Vaishali Pharma Ltd | 103 Cr. | 7.92 | 11.5/4.75 | 24.4 | 5.29 | 0.00 % | 8.93 % | 6.02 % | 2.00 |
| Concord Drugs Ltd | 93.5 Cr. | 71.0 | 92.5/61.0 | 45.8 | 36.8 | 0.00 % | 5.19 % | 2.52 % | 10.0 |
| Denis Chem Lab Ltd | 90.7 Cr. | 65.4 | 94.6/56.1 | 11.4 | 66.0 | 3.83 % | 14.0 % | 9.52 % | 10.0 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | / | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Fervent Synergies Ltd | 74.4 Cr. | 14.9 | 26.0/13.0 | 20.4 | 11.4 | 0.00 % | 7.21 % | 7.22 % | 10.0 |
| Cian Healthcare Ltd | 63.6 Cr. | 25.4 | 25.4/4.72 | 3.42 | 0.00 % | 15.1 % | 49.2 % | 10.0 | |
| Vivimed Labs Ltd | 61.1 Cr. | 7.25 | 29.4/4.75 | 25.4 | 0.00 % | 65.2 % | % | 2.00 | |
| Mangalam Drugs and Organics Ltd | 49.2 Cr. | 31.1 | 73.0/22.7 | 65.3 | 0.00 % | 14.0 % | 34.8 % | 10.0 | |
| Biofil Chemicals & Pharmaceuticals Ltd | 49.1 Cr. | 30.2 | 46.8/25.6 | 102 | 13.2 | 0.00 % | 2.97 % | 2.83 % | 10.0 |
| ANG Lifesciences India Ltd | 48.4 Cr. | 37.1 | 49.7/17.6 | 47.6 | 0.00 % | 1.14 % | 7.38 % | 10.0 | |
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 0.44/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Bharat Immunological & Biological Corporation Ltd | 38.2 Cr. | 8.84 | 22.6/7.11 | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 | |
| Bacil Pharma Ltd | 34.8 Cr. | 24.2 | 61.8/10.6 | 53.5 | 17.3 | 0.00 % | 3.93 % | 6.21 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 28.8 Cr. | 38.2 | 53.0/29.7 | 9.45 | 43.9 | 0.00 % | 12.1 % | 9.67 % | 10.0 |
| Gujarat Terce Laboratories Ltd | 27.6 Cr. | 35.4 | 59.8/29.0 | 12.4 | 12.5 | 0.00 % | 39.2 % | 30.2 % | 10.0 |
| Colinz Laboratories Ltd | 18.5 Cr. | 73.5 | 87.9/36.1 | 37.0 | 39.9 | 0.00 % | 7.20 % | 5.23 % | 10.0 |
| Checkpoint Trends Ltd | 17.3 Cr. | 31.6 | 144/28.4 | 14.1 | 42.5 | 0.00 % | 15.0 % | 12.7 % | 10.0 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 | |
| Desh Rakshak Aushdhalaya Ltd | 15.3 Cr. | 26.9 | 59.6/22.4 | 27.9 | 23.3 | 0.00 % | 7.50 % | 5.59 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 13.6 Cr. | 91.0 | 153/70.0 | 8.60 | 0.00 % | 0.28 % | 0.28 % | 10.0 | |
| Beryl Drugs Ltd | 12.8 Cr. | 25.2 | 27.6/15.9 | 20.7 | 19.5 | 0.00 % | 7.25 % | 4.34 % | 10.0 |
| Dipna Pharmachem Ltd | 10.2 Cr. | 3.89 | 25.0/3.89 | 3.89 | 23.7 | 0.00 % | 7.64 % | 5.22 % | 10.0 |
| Adline Chem Lab Ltd | 9.24 Cr. | 15.8 | 16.2/7.60 | 3.03 | 0.00 % | 1,267 % | % | 10.0 | |
| Brawn Biotech Ltd | 7.62 Cr. | 25.4 | 25.7/17.7 | 8.96 | 14.5 | 0.00 % | 0.00 % | 24.4 % | 10.0 |
| Ganga Pharmaceuticals Ltd | 7.39 Cr. | 12.5 | 14.0/9.35 | 73.9 | 14.1 | 0.00 % | 2.90 % | 1.30 % | 10.0 |
| Decipher Labs Ltd | 5.75 Cr. | 5.69 | 11.0/5.00 | 20.5 | 0.00 % | 16.7 % | 14.2 % | 10.0 | |
| Amerise Biosciences Ltd | 5.22 Cr. | 0.79 | 1.03/0.50 | 0.82 | 0.00 % | 0.37 % | 0.37 % | 1.00 | |
| Fabino Enterprises Ltd | 4.27 Cr. | 20.3 | 27.0/13.0 | 18.7 | 0.00 % | 6.22 % | 8.76 % | 10.0 | |
| Evoq Remedies Ltd | 4.08 Cr. | 1.64 | 6.11/1.35 | 17.8 | 0.00 % | 0.56 % | 0.54 % | 10.0 | |
| MPS Pharmaa Ltd | 3.98 Cr. | 2.08 | 2.08/1.57 | 0.04 | 0.00 % | 13.1 % | 177 % | 10.0 | |
| Lupin Ltd | 89,234 Cr. | 1,956 | 2,530/1,900 | 15.0 | 491 | 0.92 % | 29.9 % | 28.7 % | 2.00 |
| Aurobindo Pharma Ltd | 94,309 Cr. | 1,642 | 1,740/1,075 | 24.9 | 652 | 0.24 % | 12.9 % | 10.1 % | 1.00 |
| Mankind Pharma Ltd | 98,508 Cr. | 2,380 | 2,642/1,910 | 43.6 | 397 | 0.04 % | 13.7 % | 13.8 % | 1.00 |
| Dr Reddys Laboratories Ltd | 99,911 Cr. | 1,197 | 1,415/1,080 | 31.0 | 454 | 0.67 % | 13.0 % | 11.2 % | 1.00 |
| Cipla Ltd | 1,05,249 Cr. | 1,301 | 1,673/1,166 | 29.4 | 426 | 1.00 % | 15.5 % | 11.6 % | 2.00 |
| Laurus Labs Ltd | 1,09,924 Cr. | 2,037 | 2,065/843 | 126 | 97.3 | 0.10 % | 16.0 % | 15.2 % | 2.00 |
| Torrent Pharmaceuticals Ltd | 1,74,940 Cr. | 4,657 | 5,250/3,480 | 78.4 | 248 | 0.82 % | 15.2 % | 27.4 % | 5.00 |
| Industry Average | 17,127.26 Cr | 1,216.62 | 53.25 | 211.24 | 0.40% | 26.16% | 16.59% | 6.06 |
How to use this peer comparison
Start with similar company sizes, then compare P/E with ROCE and ROE. A lower P/E alone does not establish better value. Negative earnings, unusual items, debt and different reporting dates can make ratios unsuitable for direct comparison.
The company list is ordered by market-cap proximity to Ajanta Pharma Ltd, with P/E as a secondary comparison. The industry-average row uses available stored values across the industry, which can include companies beyond the rows shown. Missing values are not zero.
Open each company report for financial statements and its cited sources. Industry classifications indicate a research peer group, not a verified list of direct commercial competitors.
Read the full Ajanta Pharma Ltd analysis · Explore all Pharmaceuticals stocks